Investors interested in arranging a meeting with the Company’s management virtually during the conference should contact the Investor Summit conference coordinator. A live webcast of the presentation ...

Following the submission of a New Drug Application (“NDA”) to the FDA in October ... 10 mg for the treatment of acute migraine with or without aura in adults. For more information about the company, ...

There are several effective self-care methods and natural home remedies available for relieving headaches without medication.

One simple ingredient could combat your headaches and migraines more effectively than standard medication - and doctors ...

A doctor says there's a simple ingredient that could help with your migraines if the go-to medicines don't seem to be doing ...

Approximately 10 million people suffer from migraines in the UK. The condition is most common between ages 25-55, with women more likely to suffer. It’s not known what causes them and they can ...

The U.S. patient population for Revuforj in its approved indication is roughly 2,000 according to Syndax. KMT2A leukemias ...

Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...

University of Queensland researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that ...